Name: UMIN ID:
Unique ID issued by UMIN | UMIN000007216 |
---|---|
Receipt number | R000008493 |
Scientific Title | Efficacy and safety of new drugs for induction, autologous stem cell transplantation, consolidation and maintenance therapy in patients with newly diagnosed symptomatic multiple myeloma: a phase2 study |
Date of disclosure of the study information | 2012/02/02 |
Last modified on | 2018/08/17 16:31:26 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/02/02 18:18:00 | ||
2 | Update | 2012/02/06 15:23:57 | Public title |
|
3 | Update | 2012/02/06 15:24:48 | Narrative objectives1 Primary outcomes |
|
4 | Update | 2012/02/06 15:25:55 | Interventions/Control_1 Interventions/Control_1 |
|
5 | Update | 2012/02/06 15:27:05 | Address Address |
|
6 | Update | 2012/02/06 15:31:02 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
7 | Update | 2012/02/06 15:34:26 | Key secondary outcomes Key secondary outcomes |
|
8 | Update | 2012/04/16 17:27:45 | Recruitment status |
|
9 | Update | 2012/04/16 17:29:04 | Organization1 Address1 Tel1 Email1 |
|
10 | Update | 2013/02/04 12:12:06 | Recruitment status |
|
11 | Update | 2018/08/17 16:31:26 | Recruitment status Publication of results Results |